The mitral valve clip, which is marketed in the U.S. as the MitraClip, is a minimally invasive, non-surgical alternative used to repair a damaged mitral heart valve. The mitral valve clip procedure ...

Edwards today presented new data at New York Valves 2026 supporting its transcatheter aortic valve replacement (TAVR) ...

IRVINE, Calif.--(BUSINESS WIRE)-- Edwards Lifesciences Corporation (NYSE: EW) today announced the company’s SAPIEN M3 mitral valve replacement system received CE Mark for the transcatheter treatment ...

IRVINE, Calif.--(BUSINESS WIRE)--Edwards Lifesciences (NYSE: EW) today announced it has exercised its option to acquire Innovalve Bio Medical Ltd., an early-stage transcatheter mitral valve ...

Edwards Lifesciences has received CE marking for its transfemoral transcatheter mitral valve replacement system, setting up market rivalry with Abbott. Edwards’ device, dubbed Sapien M3, is the first ...

Edwards TAVR data has a strong showing at NY Valves 2026 amid intense industry competition from Abbott Laboratories and Medtronic.

Mitral valve regurgitation is a common heart valve condition in which the mitral valve cannot close properly. Cardiologists may implant mitral valve clips to help the valve close effectively. Mitral ...

Edwards' Sapien M3 approval follows Abbott's U.S. green light for its Tendyne system earlier this year; both aim to expand the population eligible to implants for tricky-to-treat mitral regurgitation.

IRVINE, Calif., Sept. 15, 2022 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW), today announced the company's PASCAL Precision transcatheter valve repair system for transcatheter ...